News
Open letter for the FDA Modernization Act
🤔 Since 1938, the FDA has required that all drugs need to be tested in animal models prior to clinical trials. However, science and technology have advanced considerably in the past years. So, it is time to change! 💪 At AlveoliX we support the initiative of the FDA Modernization Act to recognize and implement legally...
Read now
AlveoliX is part of the 2022 Lush Prize shortlist
📢 Find out who is in the running for the 2022 Lush Prize! 🏅 We are very excited to have made it to the Shortlist among many great applicants with our project “A barrier-on-chip with integrated 3D stretching: an alternative predictive tool to support decision making”. 🤞 Let’s keep our fingers crossed! See you at...
Read now
AlveoliX winner of the Swiss Medtech Award 2022
🏆 We made it! We are the winner of the Swiss Medtech Award 2022 🙏 A big thank you to the AlveoliX team for their commitment and to all the people who support us.– ARTORG Center for Biomedical Engineering Research– Insel Gruppe– Innosuisse– Bern Economic Development Agency 👏🏼 Thank you to the jury for choosing...
Read now
Close collaboration with CSL and Insel Gruppe
🌐 CSL Behring, Insel Gruppe and AlveoliX have joined forces within sitem-insel AG’s hub to improve translation and find new treatments for lung diseases. 🔬 Discover how this close collaboration works for the benefit of patients. 📰 Learn more about this cooperation success story in this article by Jasmin Joller (available in EN, DE, FR)....
Read now